​

Health Catalyst (HCAT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HCAT Stock Forecast

Health Catalyst (HCAT) stock forecast, based on 22 Wall Street analysts, predicts a 12-month average price target of $4.25, with a high of $5.00 and a low of $3.00. This represents a 66.02% increase from the last price of $2.56.

$2 $3 $4 $5 $6 $7 $8 $9 $10 High: $5 Avg: $4.25 Low: $3 Last Closed Price: $2.56

HCAT Stock Rating

Health Catalyst stock's rating consensus is Buy, based on 22 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 13 Buy (59.09%), 9 Hold (40.91%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 22 0 9 13 Strong Sell Sell Hold Buy Strong Buy

HCAT Price Target Upside V Benchmarks

TypeNameUpside
StockHealth Catalyst66.02%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Information Services Stocks 23.76%

Price Target Trends

1M3M12M
# Anlaysts-27
Avg Price Target-$3.50$4.86
Last Closing Price$2.56$2.56$2.56
Upside/Downside-36.72%89.84%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 25-48--12
Nov, 25-48--12
Oct, 25-48--12
Sep, 25-48--12
Aug, 25165--12
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 08, 2025Evercore ISI$3.00$2.903.45%17.19%
Oct 08, 2025KeyBanc$4.00$2.8540.35%56.25%
Aug 29, 2025Richard CloseCanaccord Genuity$5.00$3.6536.99%95.31%
Aug 29, 2025Summit Redstone Partners$5.00$3.6536.99%95.31%
Apr 16, 2025Scott SchoenhausKeyBanc$5.00$3.7533.33%95.31%
Mar 06, 2025Stephens$5.00$4.4312.87%95.31%
Jan 14, 2025Sean DodgeRBC Capital$7.00$6.980.29%173.44%
Sep 03, 2024Richard CloseCanaccord Genuity$11.00$7.2950.89%329.69%
Aug 26, 2024Jessica TassanPiper Sandler$11.00$7.1952.99%329.69%
Aug 08, 2024Jeff GarroStephens$7.00$5.4827.74%173.44%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 11, 2025UBSOutperformOutperformhold
Aug 27, 2025Piper SandlerOverweightNeutraldowngrade
Aug 08, 2025CitigroupBuyNeutraldowngrade
Apr 16, 2025KeyBancOverweightOverweighthold
Jan 14, 2025RBC CapitalSector PerformSector Performhold
Oct 08, 2024Evercore ISIOutperformOutperformhold
Sep 20, 2024StephensEqual-WeightEqual-Weighthold
Sep 03, 2024Canaccord GenuityBuyBuyhold
Aug 26, 2024Piper SandlerOverweightOverweighthold
Aug 09, 2024StephensBuyBuyhold

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.91$-3.23$-2.56$-2.09$-1.15----
Avg Forecast$-0.73$-0.50$-0.34$0.15$0.31$0.38$0.54$-0.33-
High Forecast$-0.72$-0.49$-0.33$0.18$0.37$0.50$0.80$-0.32-
Low Forecast$-0.73$-0.50$-0.34$0.02$0.27$0.17$0.28$-0.34-
Surprise %298.63%546.00%652.94%-1493.33%-470.97%----

Revenue Forecast

$150M $230M $310M $390M $470M $550M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$188.84M$241.93M$276.24M$295.94M$306.58M----
Avg Forecast$187.65M$240.34M$275.40M$294.47M$306.64M$337.13M$370.21M$407.91M$495.90M
High Forecast$189.27M$242.42M$278.54M$295.31M$307.44M$342.58M$370.60M$412.30M$506.23M
Low Forecast$186.36M$238.69M$272.79M$293.68M$305.51M$331.81M$369.82M$403.51M$490.08M
Surprise %0.64%0.66%0.31%0.50%-0.02%----

Net Income Forecast

$-200M $-150M $-100M $-50M $0 $50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-115.02M$-153.21M$-137.40M$-118.15M$-69.50M----
Avg Forecast$-93.07M$-28.14M$-126.22M$-118.15M$17.93M$18.73M$30.52M$-18.62M-
High Forecast$-74.45M$-27.89M$-100.97M$-94.52M$20.87M$28.09M$45.38M$-18.33M-
Low Forecast$-111.68M$-28.46M$-151.46M$-141.78M$14.99M$9.36M$15.65M$-19.12M-
Surprise %23.59%444.37%8.86%--487.61%----

HCAT Forecast FAQ

Is Health Catalyst stock a buy?

Health Catalyst stock has a consensus rating of Buy, based on 22 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 13 Buy, 9 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Health Catalyst is a favorable investment for most analysts.

What is Health Catalyst's price target?

Health Catalyst's price target, set by 22 Wall Street analysts, averages $4.25 over the next 12 months. The price target range spans from $3 at the low end to $5 at the high end, suggesting a potential 66.02% change from the previous closing price of $2.56.

How does Health Catalyst stock forecast compare to its benchmarks?

Health Catalyst's stock forecast shows a 66.02% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the healthcare information services stocks industry (23.76%).

What is the breakdown of analyst ratings for Health Catalyst over the past three months?

  • December 2025: 0% Strong Buy, 33.33% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 0% Strong Buy, 33.33% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 0% Strong Buy, 33.33% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.

What is Health Catalyst’s EPS forecast?

Health Catalyst's average annual EPS forecast for its fiscal year ending in December 2025 is $0.38, marking a -133.04% decrease from the reported $-1.15 in 2024. Estimates for the following years are $0.54 in 2026, $-0.33 in 2027, and $0 in 2028.

What is Health Catalyst’s revenue forecast?

Health Catalyst's average annual revenue forecast for its fiscal year ending in December 2025 is $337.13M, reflecting a 9.96% increase from the reported $306.58M in 2024. The forecast for 2026 is $370.21M, followed by $407.91M for 2027, and $495.9M for 2028.

What is Health Catalyst’s net income forecast?

Health Catalyst's net income forecast for the fiscal year ending in December 2025 stands at $18.73M, representing a -126.95% decrease from the reported $-69.502M in 2024. Projections indicate $30.52M in 2026, $-18.618M in 2027, and $0 in 2028.